RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 125 filers reported holding RELAY THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $75,438 | -11.8% | 8,970 | +31.7% | 0.00% | 0.0% |
| Q2 2023 | $85,546 | -23.7% | 6,811 | 0.0% | 0.00% | -25.0% |
| Q1 2023 | $112,177 | -20.7% | 6,811 | 0.0% | 0.00% | -33.3% |
| Q4 2022 | $141,533 | +9.7% | 6,811 | +17.5% | 0.01% | 0.0% |
| Q3 2022 | $129,000 | +33.0% | 5,798 | 0.0% | 0.01% | +50.0% |
| Q2 2022 | $97,000 | -40.1% | 5,798 | +7.2% | 0.00% | -33.3% |
| Q1 2022 | $162,000 | -2.4% | 5,408 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $166,000 | +14.5% | 5,408 | +17.8% | 0.01% | +20.0% |
| Q3 2021 | $145,000 | -13.7% | 4,590 | 0.0% | 0.01% | -16.7% |
| Q2 2021 | $168,000 | +30.2% | 4,590 | +23.1% | 0.01% | +20.0% |
| Q1 2021 | $129,000 | +13.2% | 3,730 | +36.0% | 0.01% | 0.0% |
| Q4 2020 | $114,000 | -2.6% | 2,743 | 0.0% | 0.01% | 0.0% |
| Q3 2020 | $117,000 | – | 2,743 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Grace Capital | 183,112 | $5,665,000 | 3.48% |
| Casdin Capital, LLC | 3,668,574 | $115,670,000 | 2.88% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $879,843,000 | 2.73% |
| BVF INC/IL | 2,049,113 | $64,609,000 | 2.52% |
| Fernwood Investment Management, LLC | 185,063 | $5,835,000 | 2.00% |
| EcoR1 Capital, LLC | 1,385,276 | $43,678,000 | 1.52% |
| Boxer Capital, LLC | 1,294,132 | $40,804,000 | 1.42% |
| Integral Health Asset Management, LLC | 140,000 | $4,414,000 | 1.27% |
| Alphabet Inc. | 1,641,497 | $51,756,000 | 1.23% |
| Bellevue Group AG | 3,755,962 | $118,426,000 | 1.20% |